Terminated NA INTERVENTIONAL 1-arm NCT05631483

COlombia DAISe FEasibility Exercise (COFEE)

A Feasibility Study for the DAISe Thrombectomy Device in Colombia

Sponsor: MIVI Neuroscience, Inc.

Interventions DAISe

Updated 4 times since 2022 Last updated: Aug 7, 2024 Started: Jun 14, 2022 Primary completion: Apr 26, 2023 Completion: Aug 2, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment/Recruitment

Other terminated trials from MIVI Neuroscience, Inc.

More terminations from MIVI Neuroscience, Inc.

This NA trial investigates Stroke, Acute Ischemic and is currently terminated or withdrawn. MIVI Neuroscience, Inc. leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Apr 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2022 — Apr 2024 [monthly]

Recruiting NA

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MIVI Neuroscience, Inc.

Data source: MIVI Neuroscience, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Itagüí, Colombia